Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

532

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Aliskiren 150 mg or 300 mg taken once daily in oral form

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 12.5 mg or 25 mg taken once daily in oral form.

Trial Locations (1)

Novartis Pharmaceuticals, East Hanover